5-(Hydroxymethyl)picolinic acid

Catalog No. :
ACXNDM538
CAS No. :
39977-41-8
Molecular Formula :
C7H7NO3
Molecular Weight :
153.14

IUPAC Name:5-(hydroxymethyl)picolinic acid

5-(Hydroxymethyl)picolinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$67.00Login to see priceIn stockInquiry
5g95%$329.00Login to see priceIn stockInquiry
10g95%$558.00Login to see priceIn stockInquiry
25g95%$1116.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Hydroxymethyl)picolinic acid
IUPAC Name5-(hydroxymethyl)picolinic acid
MDL No.MFCD11520014
Molecular FormulaC7H7NO3
Molecular Weight153.14
SMILESO=C(O)C1=NC=C(CO)C=C1
InChI KeyJFOQWSKCLFWNSW-UHFFFAOYSA-N
Synonym5-(Hydroxymethyl)picolinic acid | 39977-41-8 | 5-(hydroxymethyl)pyridine-2-carboxylic acid | MFCD11520014 | 5-Hydroxymethyl-pyridine-2-carboxylic acid | 5-(Hydroxymethyl)picolinicacid | SCHEMBL287277 | DTXSID10542789 | 2-Carboxy-5-hydroxymethylpyridine | JFOQWSKCLFWNSW-UHF
CAS No.39977-41-8
PubChem CID13518563

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACXNDM538 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKFHZ835 route compound structure diagram
    ACKFHZ83517874-79-2 In Stock
  2. Then
  3. ACXNDM538 route product structure diagram
    ACXNDM53839977-41-8 In Stock
Inquiry

2. ACXNDM538 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXNDM538 route product structure diagram
    ACXNDM53839977-41-8 In Stock
Inquiry

Comments (0)